Egg donation has been widely practiced for the past 25 years. Today, it is successfully used to treat women with a variety of disorders, including premature ovarian failure, declining ovarian function due to advanced reproductive age, avoidance of genetic disease transmission, poor oocyte quality following recurrent implantation failure during conventional assisted reproduction and age-related infertility. Interestingly oocyte donation seems to represent the most efficacious method of all assisted reproduction techniques. Moreover, success rates do not appear to vary greatly with the recipient’s age or diagnosis. Medical concerns also remain with regard to egg donation. For instance what genetic and clinical tests should every egg donor undergo? And, should all recipients be allowed to undergo egg donation, or should age, medical and mental limits be set? The wide scope of the present book clearly demonstrates the growing role of egg donation in reproductive care. Dr Gautam N Allahbadia has once again shown his significant merits and abilities by putting together an impressive and wide ensemble of some of the world’s greatest experts in the field of egg donation. The huge body of information assembled for the first time on this subject of growing importance, creates a unique and unprecedented volume. We are certain that clinicians, embryologists and other professionals involved in that sacred work of fulfilling the dream of a healthy child for those in need of egg donation, will all find this superb textbook of great help in their daily practice.
Chapter-01 Gametes and Embryo Donation: An Evolving Medical Contribution to
Chapter-02 Can we Define the Indications for Oocyte Donation?
Chapter-03 Treatment of Ovarian Failure
Chapter-04 Is Donor Egg IVF a Rational Treatment for Genetic Disorders?
Chapter-05 Reversing the Natural Decline in Human Fertility with Oocyte Donation to Women of Advanced Reproductive Age
Chapter-06 Do Recipient Age and Infertility Diagnosis Affect Pregnancy and Implantation Rates in a Donor Egg IVF Program?
Chapter-07 Donor Age is Paramount to Success in Oocyte Donation
Chapter-08 Importance of Transfer and Uterine Factors in a Donor Egg IVF Program
Chapter-09 Do Hydrosalpinges Adversely Affect Implantation in Donor Oocyte Cycles?
Chapter-10 The Effect of Prior Gravidity on the Outcomes of Egg Donation
Chapter-11 Factors that Determine Discordant Outcomes from Shared Oocytes
Chapter-12 Blastocyst Culture and Transfer in Oocyte Donation
Chapter-13 Endometriosis and Oocyte Donation
Chapter-14 The Best Donor
Chapter-15 Clinical Factors Interfering with Endometrial Receptivity
Chapter-16 The Shared Donor Oocyte Program: Advantages and Insights (Egg Recipients Sharing Oocytes from Single Donor)
Chapter-17 Egg Recipients Sharing Oocytes from Patients Undergoing IVF
Chapter-18 Does Egg Sharing Compromise the Chances of Donors or Recipients Achieving a Livebirth?
Chapter-19 Social and Financial Aspects of Egg-sharing versus Professional Egg Donation in a Donor Egg IVF Program
Chapter-20 Eggs for Sale: How Much is Too Much?
Chapter-21 Subsidized IVF: Egg-sharing as a Source of Donor Eggs
Chapter-22 Oocyte Donor Screening: The Selection Process and Cost Analysis
Chapter-23 Genetic Screening of Prospective Oocyte Donors
Chapter-24 Should Donor Egg IVF Programs Accept PCOS Women as Donors?
Chapter-25 Family Members as Gamete Donors and Surrogates
Chapter-26 Sisters of Women with Premature Ovarian Failure may not be Ideal Ovum Donors
Chapter-27 Should Nonpatient Volunteers Donate Eggs?
Chapter-28 Endometrial Receptivity in Oocyte Donation Cycles
Chapter-29 Color and Power Doppler for Assessing Endometrial Receptivity
Chapter-30 Endometrial TB-PCR: Transcription-mediated Amplification or Histopathology for Endometrial Evaluation in Donor Egg IVF?
Chapter-31 Preparation of the Endometrium for Egg Donation
Chapter-32 Long Estradiol Replacement in an Oocyte Donation Program
Chapter-33 Vaginal Progesterone Gel Preparation in a Donor Oocyte Program
Chapter-34 Role of GnRH Analog Depot Preparations in Donor Egg IVF
Chapter-35 Long Protocol is the Gold Standard for Ovarian Stimulation in Egg Donors
Chapter-36 Timing of Placental Competence in Ovum Donation
Chapter-37 Role of TVS in Assessing Endometrial and Ovarian Morphology in a Donor Egg IVF Program. Imaging Aspects: A Perspective
Chapter-38 Upper Genital Tract Screening with Hysterosonography in Patients Receiving Donated Oocytes
Chapter-39 Surrogacy: Ethical, Psychological and Legal Implications
Chapter-40 Gestational Surrogacy
Chapter-41 Role of Hysteroscopy in a Donor Egg IVF Program
Chapter-42 Counseling Recipients in a Donor Egg IVF Program
Chapter-43 Potential Psychological Attachments Formed by Egg Donors Involved in Fertility Technology
Chapter-44 Ethical and Religious Considerations in Third Party Reproduction
Chapter-45 Factors Influencing the Obstetric and Perinatal Outcomes after Oocyte Donation
Chapter-46 Pregnancy Results and Obstetric Outcomes in Patients 45 years and Older
Chapter-47 Health and Development of Donor Egg IVF Children Compared to IVF Children
Chapter-48 Donor Egg IVF: Its Regulation in India
Chapter-49 Egg-sharing and Policy Making
Chapter-50 Oocyte Donation: The Legislative Framework in Western Europe
Chapter-51 Oocyte Donation to Human Immunodeficiency Virus-1 Serodiscordant Couples
Chapter-52 Turner’s Syndrome and Oocyte Donation
Chapter-53 Cross Border or Reproductive Tourism with Special Emphasis on Donor Oocytes
Chapter-54 The Internet and Donor Egg IVF
Chapter-55 Egg Donor: Once Upon a Time—What Will You Tell Them?
Chapter-56 Risks of Oocyte Donation